Decline depth
-21.7%
From rolling 252-day high of $23.77, 102d ago.
Past the 20% Watch threshold.
-21.7%
from rolling 252-day high of $23.77 set 2026-02-03 · 102d ago
Current
$18.62
Decline depth
-21.7%
Decline σ
3.7σ
TFC
0/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
DNLI qualifies for the Watch on decline depth.
Time-frame continuity
0/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
3.7σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (3.11% per day).
The structural read
What price action says about DNLI.
DNLI qualifies for the Watch on decline depth — down -21.7% from its rolling 252-day high.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 2D (red).
Earnings on file: 2026-02-26. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $12.58
54.0% of range
52W high $23.77
Sector context · Healthcare
215 other Healthcare tickers are on Broken Stocks.
107
Red List
57
Amber
51
Watch
-34.8%
Median decline
Worst in sector: OPRX (-76.6%). Least-bad: KYMR (-20.2%). See all Healthcare listings →
Related — same sector
Closest decliners to DNLI
Watch Recovering
QTTB
Q32 Bio Inc.
Amber List
PHG
Koninklijke Philips N.V. NY Reg
Amber List
ANIP
ANI Pharmaceuticals, Inc.
Watch
OMCL
Omnicell, Inc.
Watch
ENTA
Enanta Pharmaceuticals, Inc.
Watch
BMRN
BioMarin Pharmaceutical Inc.
Questions about DNLI
What people ask.
Why is DNLI on Broken Stocks?
DNLI qualifies for the Watch on decline depth. It is down -21.7% from its rolling 252-day high of $23.77, set on 2026-02-03 — 102d ago.
Is DNLI a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. DNLI is down -21.7% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is DNLI a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is DNLI trading inside its 52-week range?
At $18.62, DNLI sits 54.0% of the way from its 52-week low ($12.58) to its 52-week high ($23.77). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has DNLI been declining?
The current 21.7% decline accrued over 102d, which annualizes to roughly -77.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does DNLI compare to its sector?
There are 215 other Healthcare tickers on Broken Stocks: 107 Red, 57 Amber, 51 Watch, with 24 showing recovering structural signals. Median sector decline is -34.8% — DNLI's decline is shallower than the sector median.
Does DNLI's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-02-26) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.